Trinity Biotech TRIB
NASDAQ TRIB
$6.79 +0.04 (+0.56%)
As of: Sep 30, 2026 · 1:03 PM EDT

Trinity Biotech Plc (TRIB) EBITDA (2021 - 2024)

Updated

Trinity Biotech (TRIB) posted EBITDA of -$14.4 million for the year ended Dec 31, 2025, compared with -$19.98 million a year earlier.

Analysis

Trinity Biotech Plc (TRIB) EBITDA (2021 - 2024) Analysis & Trends

Since the year ended Dec 31, 2009, Trinity Biotech has reported EBITDA for 17 years.

  • The figure for the year ended Dec 31, 2025 stands as the highest annual EBITDA since the year ended Dec 31, 2021.
  • Business Quant data shows TRIB's EBITDA at -$19.98 million in the year ended Dec 31, 2024, -$26.1 million in the year ended Dec 31, 2023, -$18.43 million in the year ended Dec 31, 2022 and $4.86 million in the year ended Dec 31, 2021 (+226.9%).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -11.40 Mn
Sep 30, 2024 -1.96 Mn
Jun 30, 2024 -3.62 Mn
Mar 31, 2024 -2.51 Mn
Dec 31, 2023 -3.32 Mn
Sep 30, 2023 -4.39 Mn
Jun 30, 2023 -14.49 Mn
Mar 31, 2023 -3.67 Mn
Dec 31, 2022 -7.94 Mn
Sep 30, 2022 -7.87 Mn
Jun 30, 2022 -1.64 Mn
Mar 31, 2022 -988,000.00
Dec 31, 2021 791,000.00
Sep 30, 2021 3.00 Mn
Jun 30, 2021 458,000.00
API Access

Trinity Biotech Plc EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=TRIB&period=max&api_key=YOUR_API_KEY